Follow
Jonathan Millar
Jonathan Millar
BG Pandemic Science Hub, CIR, University of Edinburgh
Verified email at ed.ac.uk - Homepage
Title
Cited by
Cited by
Year
Clinical Evidence Does Not Support Corticosteroid Treatment for 2019-nCoV Lung Injury
CD Russell, JE Millar, JK Baillie
Lancet 395 (10223), 473-475, 2020
25212020
Genetic mechanisms of critical illness in Covid-19
E Pairo-Castineira, S Clohisey, L Klaric, AD Bretherick, K Rawlik, D Pasko, ...
Nature 591 (7848), 92-98, 2021
14192021
Mapping the human genetic architecture of COVID-19
Nature 600, 472-477, 2021
807*2021
The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology
JE Millar, JP Fanning, CI McDonald, DF McAuley, JF Fraser
Critical Care 20 (1), 387, 2016
7032016
Whole-genome sequencing reveals host factors underlying critical COVID-19
A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ...
Nature 607 (7917), 97-103, 2022
2982022
Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic …
JJ McNamee, MA Gillies, NA Barrett, GD Perkins, W Tunnicliffe, D Young, ...
JAMA, 10.1001/jama.2021.13374, 2021
1722021
Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review
M Fitzgerald, J Millar, B Blackwood, A Davies, SJ Brett, ...
Critical Care 18 (3), 222, 2014
1192014
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu, I Nassiri, ...
Nature 617 (7962), 764-768, 2023
1072023
The use of high-flow nasal oxygen therapy in the management of hypercarbic respiratory failure
J Millar, S Lutton, O'Connor P
Therapeutic Advances in Respiratory Disease 8 (2), 63-64, 2014
842014
Low flow rate alters haemostatic parameters in an ex-vivo extracorporeal membrane oxygenation circuit
KK Ki, MR Passmore, CHH Chan, MV Malfertheiner, JP Fanning, ...
Intensive care medicine experimental 7 (1), 1-15, 2019
622019
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium …
LF Reyes, S Murthy, E Garcia-Gallo, M Irvine, L Merson, I Martin-Loeches, ...
ERJ open research 8 (1), 2022
602022
Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis and COVID 19 infection: optimising the therapeutic potential
E Gorman, J Millar, D McAuley, C O’Kane
Expert Review of Respiratory Medicine, 2020
552020
Lyrica nights – Recreational Pregabalin abuse in an urban Emergency Department
J Millar, S S, W N, L S
Emergency Medicine Journal 30 (10), 874, 2013
532013
SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures
RL Winslow, J Zhou, EF Windle, I Nur, R Lall, C Ji, JE Millar, PM Dark, ...
Thorax, doi: 10.1136/thoraxjnl-2021-218035, 2021
462021
Dynamic data-driven meta-analysis for prioritisation of host genes implicated in COVID-19
N Parkinson, N Rodgers, M Head Fourman, B Wang, M Zechner, ...
Scientific reports 10 (1), 22303, 2020
412020
An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients
G Li Bassi, JY Suen, HJ Dalton, N White, S Shrapnel, JP Fanning, ...
Critical Care 25 (1), 199, 2021
362021
Acquired von Willebrand syndrome in respiratory extracorporeal life support: a systematic review of the literature.
MV Malfertheiner, LP Pimenta, VV Bahr, JE Millar, NG Obonyo, JY Suen, ...
Critical Care & Resuscitation 19 (Supplement 1), 45-52, 2017
352017
Design and rationale of the COVID-19 Critical Care Consortium international, multicentre, observational study
GL Bassi, J Suen, AG Barnett, A Corley, J Millar, J Fanning, S Colombo, ...
BMJ open 10 (12), e041417, 2020
33*2020
Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study
JE Millar, L Neyton, S Seth, J Dunning, L Merson, S Murthy, CD Russell, ...
Scientific Reports 12 (1), 6843, 2022
32*2022
Administration of mesenchymal stem cells during ECMO results in a rapid decline in oxygenator performance
JE Millar, V von Bahr, MV Malfertheiner, KK Ki, MA Redd, N Bartnikowski, ...
Thorax 74 (2), 194-196, 2019
312019
The system can't perform the operation now. Try again later.
Articles 1–20